Ledger.Open graph →
SEC Form D · Amendment · filed May 14, 2018

BioClin Therapeutics, Inc

Offering
$50.0M
Sold
$50.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Leandro, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Steve L. Abella · San Leandro, CAExecFouad L. Azzam · San Ramon, CADirectorGraeme L. Currie · San Leandro, CAExecDavid L. Kabakoff · San Leandro, CADirectorMarten L. Steen · San Ramon, CADirectorChristian L. Richard · San Ramon, CADirectorJoel L. Jean-Mairet · San Ramon, CADirectorJoseph L. Turner · Menlo Park, CADirectorStephen W. Lau · San Ramon, CAExec · DirectorMarten L. Steen · San Ramon, CADirectorChristian L. Richard · San Ramon, CADirectorJoel L. Jean-Mairet · San Ramon, CADirectorSteve L. Abella · San Leandro, CAExecFouad L. Azzam · San Ramon, CADirectorJoseph L. Turner · San Ramon, CADirectorGraeme L. Currie · San Leandro, CAExecDavid L. Kabakoff · San Leandro, CADirectorStephen W. Lau · San Ramon, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗